Analyst: G1 Minimizes the Carnage of Chemotherapy: https://t.co/rh9mFNghwp

ROTH Capital Partners initiates coverage on U.S. oncology biopharma G1 Therapeutics that is now filing an NDA.

$GTHX #Chemotherapy #Cancer #Healthcare #Stocks @G1Therapeutics https://t.co/Os18ocAkYw